Acadia Pharmaceuticals (ACAD) EBT Margin (2010 - 2026)
Acadia Pharmaceuticals (ACAD) recorded quarterly EBT Margin of 1.49% in Q1 2026, down 83.89% quarter-over-quarter from 9.26% in Q4 2025, and down 989.0% on a YoY basis from 0.17% in Q1 2025.
Acadia Pharmaceuticals (ACAD) EBT Margin (2010 - 2026) Analysis & Trends
Acadia Pharmaceuticals' EBT Margin history runs 17 years deep, the most recent figure standing at 1.49% for Q1 2026.
- In Q1 2026, EBT Margin fell 989.0% year-over-year to 1.49%; the TTM figure through Mar 2026 stood at 10.51% (down 1608.0% YoY), while the FY2025 annual figure was 12.96%, down 1398.0% from the prior year.
- EBT Margin was 1.49% for Q1 2026 at Acadia Pharmaceuticals, down from 9.26% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 62.05% in Q4 2024 to a low of 97.49% in Q1 2022.
- Historically, EBT Margin has averaged 3.39% across 5 years, with a median of 9.26% in 2025.
- The sharpest annual moves came in 2023 and 2025: EBT Margin surged 5956 bps in 2023, then slumped 5278 bps in 2025.
- A 5-year view of EBT Margin shows it stood at 29.92% in 2022, then surged by 157 bps to 17.17% in 2023, then surged by 261 bps to 62.05% in 2024, then plunged by 85 bps to 9.26% in 2025, then plunged by 84 bps to 1.49% in 2026.
- The last three EBT Margin figures came in at 1.49% (Q1 2026), 9.26% (Q4 2025), and 16.0% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 6.40% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 41.95% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Acadia Pharmaceuticals | 3.68 Bn | 2.83 Bn | 243.27 Mn | 1.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.49% |
| Dec 31, 2025 | 9.26% |
| Sep 30, 2025 | 16.00% |
| Jun 30, 2025 | 15.19% |
| Mar 31, 2025 | 11.38% |
| Dec 31, 2024 | 62.05% |
| Sep 30, 2024 | 15.50% |
| Jun 30, 2024 | 15.37% |
| Mar 31, 2024 | 10.20% |
| Dec 31, 2023 | 17.17% |
| Sep 30, 2023 | -24.61% |
| Jun 30, 2023 | 3.84% |
| Mar 31, 2023 | -37.94% |
| Dec 31, 2022 | -29.92% |
| Sep 30, 2022 | -20.20% |
| Jun 30, 2022 | -24.95% |
| Mar 31, 2022 | -97.49% |
| Dec 31, 2021 | -32.81% |
| Sep 30, 2021 | -11.24% |
| Jun 30, 2021 | -37.67% |